BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernandes BF, Odashiro AN, Saraiva VS, Logan P, Antecka E, Burnier MN Jr. Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma. J Carcinog 2007;6:6. [PMID: 17445277 DOI: 10.1186/1477-3163-6-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Rantala ES, Hernberg MM, Piperno-Neumann S, Grossniklaus HE, Kivelä TT. Metastatic uveal melanoma: The final frontier. Prog Retin Eye Res 2022;:101041. [PMID: 34999237 DOI: 10.1016/j.preteyeres.2022.101041] [Reference Citation Analysis]
2 Beroukhim K, Pourang A, Eisen DB. Risk of second primary cutaneous and noncutaneous melanoma after cutaneous melanoma diagnosis: A population-based study. J Am Acad Dermatol 2020;82:683-9. [PMID: 31626886 DOI: 10.1016/j.jaad.2019.10.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sztramska A, Dymerska D, Chwirot BW. Skin layer-specific Melan-A expression during progression of human cutaneous melanoma: implications for diagnostic applications of the marker. Melanoma Res 2008;18:259-67. [PMID: 18626310 DOI: 10.1097/CMR.0b013e328303beac] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Triozzi PL, Aldrich W, Crabb JW, Singh AD. Spontaneous cellular and humoral tumor antigen responses in patients with uveal melanoma. Melanoma Res 2015;25:510-8. [PMID: 26397048 DOI: 10.1097/CMR.0000000000000207] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Jungbluth AA. Serological reagents for the immunohistochemical analysis of melanoma metastases in sentinel lymph nodes. Semin Diagn Pathol 2008;25:120-5. [PMID: 18697716 DOI: 10.1053/j.semdp.2008.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
6 Rashid AB, Grossniklaus HE. Clinical, pathologic, and imaging features and biological markers of uveal melanoma. Methods Mol Biol 2014;1102:397-425. [PMID: 24258990 DOI: 10.1007/978-1-62703-727-3_21] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
7 Ramos-vara JA, Miller MA. Immunohistochemical Identification of Canine Melanocytic Neoplasms With Antibodies to Melanocytic Antigen PNL2 and Tyrosinase: Comparison With Melan A. Vet Pathol 2011;48:443-50. [DOI: 10.1177/0300985810382095] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
8 Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort RN, Jia R, Shields JA, Damato BE. Uveal melanoma. Nat Rev Dis Primers 2020;6:24. [PMID: 32273508 DOI: 10.1038/s41572-020-0158-0] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 34.5] [Reference Citation Analysis]
9 Kyrgidis A, Tzellos TG, Triaridis S. Melanoma: Stem cells, sun exposure and hallmarks for carcinogenesis, molecular concepts and future clinical implications. J Carcinog 2010;9:3. [PMID: 20442802 DOI: 10.4103/1477-3163.62141] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.4] [Reference Citation Analysis]
10 Fernandes BF, Belfort RN, Di Cesare S, Burnier MN Jr. Circulating uveal melanoma cells: should we test for them? Can J Ophthalmol. 2008;43:155-158. [PMID: 18347616 DOI: 10.3129/i08-011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]